Corcept Therapeutics Inc. (CORT)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

36

0

2

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Sep-24 8:24 PM View:	03-Sep-24 Payment of Exercise ($5.05K)	Mokari Atabak Chief Financial Officer		Corcept Therapeutics Inc. - CORT	6% 11.86K to 12.52K	0	0	--	--	Show Txns Hide Txns

01-Oct-24 7:55 PM View:	01-Oct-24 Planned Option Sale ($509.08K)	Robb Gary Charles Chief Business Officer		Corcept Therapeutics Inc. - CORT	(9%) 35.54K to 32.44K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 8:04 PM View:	03-Sep-24 Planned Option Sale ($353.00K)	Guyer William Chief Development Officer		Corcept Therapeutics Inc. - CORT	(4%) 6.04K to 5.8K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 8:08 PM View:	03-Sep-24 Payment of Exercise ($8.19K)	Maduck Sean See Remarks		Corcept Therapeutics Inc. - CORT	1% 104.4K to 105.08K	0	0	--	--	Show Txns Hide Txns

05-Sep-24 8:27 PM View:	03-Sep-24 Payment of Exercise ($4.55K)	Lyon Joseph Douglas See Remarks		Corcept Therapeutics Inc. - CORT	7% 9.29K to 9.9K	0	0	--	--	Show Txns Hide Txns